Exuma Biotech Company
EXUMA Biotech is a clinical-stage biotechnology company that focuses on discovering and developing CAR-T cell products for solid tumors.
Headquarters:
Grand Cayman, Midland, Cayman Islands
Industry:
CAR-T
Estimated Revenue:
$1M to $10M
Investors Number:
7
Funding Status:
Early Stage Venture
Last Funding Type:
Series B
Founded Date:
2015-01-01
Total Funding:
107000000
Last Funding Date:
2021-12-21